AbbVie Inc. Cash & Short-Term Investments 2010-2026 | ABBV
Beta
What is AbbVie Inc.'s current cash & short-term investments?
AbbVie Inc. (ABBV) annual cash & short-term investments for 2025 was $5.26B, a 5.36% decline from 2024. AbbVie Inc. cash & short-term investments for the quarter ending March 31, 2026 was $9.39B.
What was AbbVie Inc.'s cash & short-term investments in 2024?
AbbVie Inc. annual cash & short-term investments for 2024 was $5.55B, a 56.66% decline from 2023.
What was AbbVie Inc.'s cash & short-term investments in 2023?
AbbVie Inc. annual cash & short-term investments for 2023 was $12.82B, a 38.87% increase from 2022.
What is AbbVie Inc.'s 5-year cash & short-term investments CAGR?
AbbVie Inc. cash & short-term investments grew at a compound annual growth rate (CAGR) of 9.12% from FY2020 to FY2025, going from $8.48B to $5.26B over 5 years.
Cash & Short-Term Investments History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Declining
CAGR-9.1%
FY2020
$8.48B
→
FY2025
$5.26B
10111213141516171819202122232425
5 years selected
Cash & Short-Term Investments History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $5.26B | -5.4% | 10-K |
| FY2024 | $5.55B | -56.7% | 10-K |
| FY2023 | $12.82B | +38.9% | 10-K |
| FY2022 | $9.23B | -6.1% | 10-K |
| FY2021 | $9.83B | +15.9% | 10-K |
| FY2020 | $8.48B | -78.8% | 10-K |
| FY2019 | $39.92B | +395.3% | 10-K |
| FY2018 | $8.06B | -17.7% | 10-K |
| FY2017 | $9.79B | +52.4% | 10-K |
| FY2016 | $6.42B | -23.6% | 10-K |
| FY2015 | $8.41B | +0.4% | 10-K |
| FY2014 | $8.37B | -15.4% | 10-K |
| FY2013 | $9.89B | +24.1% | 10-K |
| FY2012 | $7.98B | +29440.7% | 10-K |
| FY2011 | $27.0M | +170.0% | 10-K |
| FY2010 | $10.0M | - | 10-K |
Company: AbbVie Inc.Ticker: ABBVSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →